LOGIN  |  REGISTER
Astria Therapeutics
Recursion

Health Catalyst Acquires ERS, Bolsters Tech-Enabled Managed Services Offering with Data Abstraction and Oncology Registry Management Capabilities

November 02, 2023 | Last Trade: US$3.70 0.14 -3.65

SALT LAKE CITY, Nov. 2, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has acquired Electronic Registry Systems, Inc. (ERS), a market leader in cancer registry software and services.

Headquartered in Cincinnati, Ohio, ERS provides cancer registry compliance and informatics services to enable customers to achieve their cancer center clinical and business objectives with a goal of improving cancer care for every patient. ERS has provided solutions to the cancer registry field since 1989 and is widely recognized for its flagship platform solution, CRStar. Specifically designed for Certified Tumor Registrars, the CRStar platform records and reports vital cancer patient information to oncology registries.

CRStar, in conjunction with ARMUS by Health Catalyst, strengthens Health Catalyst's comprehensive data abstraction and registry management capabilities and will enhance the company's Tech-Enabled Managed Services (TEMS) offering within the chart abstraction domain.

"This acquisition brings together two organizations deeply aligned in our belief in the power of data and analytics to drive improved clinical, operational, and financial outcomes," said Dan Burton, CEO of Health Catalyst. "By combining our strengths, we're well-positioned to support future TEMS growth in data abstraction and registry management within the cardiology and oncology domains.  I'm confident we are better equipped to achieve our mission with ERS employees on our team."

Commenting on the acquisition, CEO of ERS Rohit Nayak shared, "As a leading cancer registry software and informatics platform, ERS has played a key role right from the early days of the industry. We have remained steadfast in our mission to help cancer centers improve cancer care for every patient, and with Health Catalyst, we know we are best positioned to expand on this vision in new ways. We are excited to be a part of the Health Catalyst family and look forward to continuing to grow our collaboration and partnership with our clients and partners."

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact:

Amanda Hundt
Vice President, Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
575-491-0974

C4 Therapeutics

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page